Making the Move: A Look into the Career Transition from Pharma/Biotech to CRO
In our recruitment process we are often asked by those coming from pharma & biotech careers, “what’s a day in the life like at a…
Impact of Pre-Existing Immunogenicity Against AAV on Gene Therapy Trials
The concept of using pre-existing immunogenicity as an exclusion criteria for gene therapy clinical trials is changing. BioAgilytix’s Chief Scientific Officer, Dr. Jim McNally, explores…
Behind the Science Perspectives with Dr. Jim McNally, BioAgilytix’s Chief Scientific Officer
We recently sat down with Dr. Jim McNally for a Q&A to hear his "Behind the Science" perspectives on the industry and where he thinks…
What’s Happening at the 14th WRIB Virtual Meeting?
We've compiled a guide to the presentations & forums our BioAgilytix team members will be participating in throughout the 2020 WRIB Virtual Meeting so you…
Behind the Science with Dr. Frank Horling, BioAgilytix’s New General Manager, Europe
Did you know that our new General Manager, Europe, Dr. Frank Horling, was a client of BioAgilytix before joining our team? We asked him to…
Answering Your Questions on Developing a Relative Potency Assay for an Anti-Influenza mAb
Dr. Jeff Patrick answers questions on how BioAgilytix translated a diagnostic virus neutralization method to a quantitative relative potency assay for an anti-viral antibody.
The Power of Being NYCE
A recent study using triple-edited ‘NYCE’ cells shows the possibilities of multiplex genome editing to effectively treat complex diseases like some cancers. We explore the…
New Research on the Diagnostic Journey of Patients with Ankylosing Spondylitis
BioAgilytix's Regan Reynolds shares how her own diagnostic journey with Ankylosing Spondylitis (AS) inspired her to participate in a non-interventional research project on how AS…
Turning Around a Troubled Study: A Rescue Project Success Story
When you have a program that has stalled or gone off schedule, it is vital to team up with a CRO laboratory that is capable…
Webinar Sneak Peek: Accelerating Testing of Therapeutics to Neutralize Viral Infections
On May 7, we'll be hosting webinar highlighting the importance of streamlining the time & cost of bioanalytical testing to support therapeutic development for viral…